ReviewDecompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: A systematic review and meta-analysis
Introduction
Malignant middle cerebral artery infarction (mMCAI), which accounts for up to 8% of all hospitalized ischemic stroke, is associated with a high fatality of 80%, despite intensive care-based treatment.1 Most patients experience neurological deterioration and transtentorial herniation within 72–96 h.2 For the therapy strategies, conservative medical treatment consisted of hyperventilation, mannitol, and sedation has not been supported by sufficient evidence of efficacy from clinical trials.3, 4 Decompressive hemicraniectomy (DHC), which aims at relieving refractory intracranial hypertension and brainstem compression by removing a part of skull and opening the dura to accommodate the swelling cerebral tissue, has been studied since 19565 and has become an attractive option for patients with mMCAI.
A previous meta-analysis, completed by Cruz-Flores et al.,6 confirmed the beneficial effects of DHC in decreasing the mortality and improving functional outcome in patients with mMCAI aged ≤60 years, as reported in three European randomized controlled trials (RCTs).7, 8, 9 Subsequently, guidelines from the American Heart Association/American Stroke Association (AHA/ASA) recommended DHC for mMCAI patients aged <60 years with a level of evidence of I.1 However, restricted to the limited RCTs, the efficacy of DHC in patients aged >60 years remained unclear. Recently, three more RCTs with additional 187 patients with an age limit of up to 80 years were published.10, 11, 12 Whether these reports change the previous conclusions and whether patients with mMCAI aged >60 years benefit from DHC are unclear. To address these issues, we conducted an updated meta-analysis to evaluate the effect of DHC in patients with mMCAI.
Section snippets
Literature search and inclusion criteria
A systematic literature search of PubMed, EMBASE, and the Cochrane Library Central Register of Control Trials, was conducted by two reviewers (M−H Y and H–Y L) to identify all the relevant articles published up to June 15, 2014. The search used key terms including hemicraniectomy, decompressive craniectomy, surgical decompression, middle cerebral artery, and stroke. No language and human subject restrictions were imposed. Subsequently, we also searched and evaluated the reference lists of
Study identification and selection
The initial search strategy identified 1426 articles. Of these, 1414 articles were removed because of duplicate studies and various other reasons (reviews/commentaries/letters, non-randomized control studies, or irrelevant to our analysis) based on the titles and abstracts. The remaining 12 were retrieved for full text review. Of these, six were excluded because two were duplicated data,16, 17 one was a non-randomized trial,18 one was terminated,19 one was awaiting assessment,20 and one
Discussion
This is an updated meta-analysis of six RCTs comprising of 314 patients to evaluate the efficacy of DHC in adult patients with mMCAI. The results of the present meta-analysis confirm the beneficial role of DHC in reducing mortality, death or major disability (mRS score >3) and death or severe disability (mRS score >4) in patients aged 18–80 years, although with a non-significant increase in the proportion of survivors with major disability (mRS score: 4–5). Specifically, a subgroup analysis
Acknowledgment
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
References (36)
- et al.
Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives
Lancet Neurol
(2009) - et al.
Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial
Lancet Neurol
(2009) - et al.
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials
(1996) - et al.
Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association
Stroke – J Cereb Circ
(2014) - et al.
Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review
Crit Care Med
(2003) - et al.
Antiedema therapy in ischemic stroke
Stroke – J Cereb Circ
(2007) Encephalomalacia simulating the clinical and radiological aspects of brain tumor; a report of 6 cases
J Neurosurg
(1956)- et al.
Surgical decompression for cerebral oedema in acute ischaemic stroke
Cochrane Database Syst Rev
(2012) - et al.
Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial)
Stroke – J Cereb Circ
(2007) - et al.
Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial
Stroke – J Cereb Circ
(2007)
Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old
Neurocritical Care
Preliminary results of randomized controlled study on decompressive craniectomy in treatment of malignant middle cerebral artery stroke
Medicina (Kaunas, Lithuania)
Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke
N Engl J Med
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses
Ann Intern Med
Measuring inconsistency in meta-analyses
BMJ
Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial
Stroke – J Cereb Circ
Early decompressive hemicraniectomy following malignant ischemic stroke: the crucial role of timing
Curr Neurol Neurosci Rep
Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke
Stroke – J Cereb Circu
Cited by (41)
Role of decompressive craniectomy
2021, Essentials of Evidence-Based Practice of Neuroanesthesia and Neurocritical CarePerioperative Management of Acute Central Nervous System Injury
2021, Perioperative Medicine: Managing for Outcome, Second EditionDecompressive Craniectomy for Infarction and Intracranial Hemorrhages
2021, Stroke: Pathophysiology, Diagnosis, and ManagementClinical determination of serum nardilysin levels in predicting 30-day mortality among adults with malignant cerebral infarction
2019, Clinica Chimica ActaCitation Excerpt :Among this group of MCI patients, 30-day mortality was 54.5%, which is similar to the previously reported data [17–21]. Up to now, decompressive craniectomy might be a good choice for such patients [10–13]. However, because of the poor prognosis, some relatives decline decompressive craniectomy for it.
- 1
These authors contributed equally to this work.